Rubin Benjamin, Taglienti Anthony, Rothman Robert F, Marcus Craig H, Serle Janet B
Department of Ophthalmology, Mount Sinai School of Medicine, New York, NY, USA.
J Glaucoma. 2008 Jun-Jul;17(4):287-92. doi: 10.1097/IJG.0b013e318031676c.
To assess effectiveness of selective laser trabeculoplasty (SLT) in lowering intraocular pressure (IOP) in patients with steroid-induced elevated IOP.
Retrospective review of 7 patients (7 eyes) with IOP elevation after intravitreal triamcinolone acetonide (4.0 mg/0.1 mL) injections for macular edema (6 patients) or central retinal vein occlusion (1 patient). Three patients had preexisting open angle glaucoma; 2 patients had preexisting ocular hypertension. Time between intraocular corticosteroid injection and subsequent increased IOP ranged from 5 to 29 weeks. After unsuccessful maximum tolerated medical therapy, patients underwent unilateral SLT between April 2003 and June 2005. IOP was measured 4 weeks prelaser; on the day of laser; within 3 weeks, and at 1, 3, and 6 months postlaser. Two-sample t test was used for analysis.
The pre-SLT and post-SLT IOP measurements were the major outcome measures used to define the relative success of the SLT procedure. Seven patients were taking 4.0+/-0.8 ocular hypotensive medications before SLT. Preoperative IOP (mm Hg+/-SD) 38.4+/-7.3 decreased postoperative to 25.6+/-7.1 within 3 weeks (P<0.003), 25.9+/-8.8 at 1 month (P<0.007), 23.9+/-10.6 at 3 months (P<0.006), and 15.7+/-2.2 at 6 months (P<0.001). Four patients underwent a second SLT procedure. Two patients failed after the 3-month visit. IOP in fellow eyes of all patients was unchanged (P>0.080).
SLT lowered (P<0.007) IOP in 5 eyes of 7 patients with steroid-induced increased IOP from 3 weeks to 6 months postoperative. Two patients required additional surgical procedures. Repeat SLT treatments may be necessary. SLT is a temporizing procedure to consider in patients with steroid-induced elevated IOP.
评估选择性激光小梁成形术(SLT)降低类固醇诱导性眼压升高患者眼压(IOP)的有效性。
回顾性分析7例(7只眼)患者,这些患者在玻璃体内注射曲安奈德(4.0mg/0.1mL)治疗黄斑水肿(6例)或视网膜中央静脉阻塞(1例)后出现眼压升高。3例患者既往有开角型青光眼;2例患者既往有高眼压症。眼内注射皮质类固醇与随后眼压升高之间的时间间隔为5至29周。在最大耐受药物治疗失败后,患者于2003年4月至2005年6月期间接受了单侧SLT治疗。在激光治疗前4周、激光治疗当天、激光治疗后3周内以及激光治疗后1、3和6个月测量眼压。采用两样本t检验进行分析。
SLT术前和术后的眼压测量是用于定义SLT手术相对成功与否的主要观察指标。7例患者在SLT术前服用4.0±0.8种降眼压药物。术前眼压(mmHg±标准差)为38.4±7.3,术后3周降至25.6±7.1(P<0.003),1个月时为25.9±8.8(P<0.007),3个月时为23.9±10.6(P<0.006),6个月时为15.7±2.2(P<0.001)。4例患者接受了第二次SLT手术。2例患者在3个月随访后治疗失败。所有患者对侧眼的眼压未发生变化(P>0.080)。
SLT使7例类固醇诱导性眼压升高患者中的5只眼在术后3周内至6个月时眼压降低(P<0.007)。2例患者需要额外的手术治疗。可能需要重复进行SLT治疗。对于类固醇诱导性眼压升高的患者,SLT是一种可考虑的临时治疗方法。